ITK, A T-CELL-SPECIFIC TYROSINE KINASE GENE INDUCIBLE BY INTERLEUKIN-2

被引:250
|
作者
SILICIANO, JD [1 ]
MORROW, TA [1 ]
DESIDERIO, SV [1 ]
机构
[1] JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205
关键词
PROTEIN-TYROSINE KINASES; LYMPHOCYTES-T; LYMPHOKINES; LYMPHOCYTE ACTIVATION;
D O I
10.1073/pnas.89.23.11194
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
T lymphocytes are activated by interactions with antigens, lymphokines, and cell adhesion molecules. Tyrosine phosphorylation has been implicated as important in signaling through each of these pathways, but except for p56lck, a member of the Src family that associates with CD4 and CD8, the protein-tyrosine kinases involved have not been defined. We describe here a tyrosine kinase gene that we have designated itk (for IL-2-inducible T-cell kinase). The itk gene specifies a 72-kDa protein-tyrosine kinase that is related to members of the Src family but lacks two features characteristic of Src kinases: an N-terminal myristoylation consensus sequence and a regulatory tyrosine residue near the C terminus. Analysis of mouse tissues and cell lines indicates that itk is specifically expressed in the T-cell lineage, suggesting that the tyrosine kinase encoded by itk functions in a signal transduction pathway unique to T lymphocytes. On addition of IL-2 to responsive T cells, itk RNA increases in parallel with that of IL-2Ralpha, implicating itk in T-cell activation.
引用
收藏
页码:11194 / 11198
页数:5
相关论文
共 50 条
  • [21] Effect of Interleukin-2 Inducible Kinase (ITK) on the Temporal Dynamics of TCR Signaling in CD8 T cells
    Hunkins, Josh
    Perrenoud, Loni
    Schoenbach, Mary
    Ono, Masahiro
    Berg, Leslie J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [22] Design, synthesis and structure-activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)
    Trani, Giancarlo
    Barker, John J.
    Bromidge, Steven M.
    Brookfield, Frederick A.
    Burch, Jason D.
    Chen, Yuan
    Eigenbrot, Charles
    Heifetz, Alexander
    Ismaili, M. Hicham A.
    Johnson, Adam
    Krulle, Thomas M.
    MacKinnon, Colin H.
    Maghames, Rosemary
    McEwan, Paul A.
    Montalbetti, Christian A. G. N.
    Ortwine, Daniel F.
    Perez-Fuertes, Yolanda
    Vaidya, Darshan G.
    Wang, Xiaolu
    Zarrin, Ali A.
    Pei, Zhonghua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (24) : 5818 - 5823
  • [23] Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders
    Reneau, John C.
    Hwang, Steven R.
    Murga-Zamalloa, Carlos A.
    Buggy, Joseph J.
    Janc, James W.
    Wilcox, Ryan A.
    BLOOD, 2018, 132
  • [24] The Outcome of Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Isolated CD4 (+) T-cell Deficiency with Interleukin-2 Inducible T-cell Kinase (ITK) Gene Defect
    Yuksel, Meltem Kurt
    Ozdemir, Zehra Narli
    Sahin, Ugur
    Ayvaz, Deniz Cagdas
    Atikcan, Deniz Turkum
    Sertesen, Elif
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Aslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Akan, Hamdi
    Ilhan, Osman
    Beksac, Meral
    Gurman, Gunhan
    Ikinciogullari, Aydan
    BONE MARROW TRANSPLANTATION, 2018, 53 : 533 - 534
  • [25] Interleukin-2 inducible T cell kinase (ITK) may participate in the anti-bacterial immune response of Nile tilapia via regulating T-cell activation
    Liang, Wei
    Li, Kunming
    Zhang, Qian
    Li, Kang
    Ai, Kete
    Zhang, Jiansong
    Jiao, Xinying
    Li, Jiaqi
    Wei, Xiumei
    Yang, Jialong
    FISH & SHELLFISH IMMUNOLOGY, 2022, 127 : 419 - 426
  • [26] Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)
    Wang, Xueying
    Xue, Gang
    Pan, Zhengying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
  • [27] Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells
    Mammadli, Mahinbanu
    Harris, Rebecca
    Suo, Liye
    May, Adriana
    Gentile, Teresa
    Waickman, Adam T.
    Bah, Alaji
    August, Avery
    Nurmemmedov, Elmar
    Karimi, Mobin
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (12):
  • [28] Discovery and Structure-Activity Relationship of 3-Aminopyrid-2-ones as Potent and Selective Interleukin-2 Inducible T-Cell Kinase (Itk) Inhibitors
    Charrier, Jean-Damien
    Miller, Andrew
    Kay, David P.
    Brenchley, Guy
    Twin, Heather C.
    Collier, Philip N.
    Ramaya, Sharn
    Keily, Shazia B.
    Durrant, Steven J.
    Knegtel, Ronald M. A.
    Tanner, Adam J.
    Brown, Kieron
    Curnock, Adam P.
    Jimenez, Juan-Miguel
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) : 2341 - 2350
  • [29] Synthesis and biological evaluation of novel (4 or 5-aryl)pyrazolyl-indoles as inhibitors of interleukin-2 inducible T-cell kinase (ITK)
    Velankar, Avdhoot D.
    Quintini, Gianluca
    Prabhu, Arati
    Weber, Alexander
    Hunaeus, Gundula
    Voland, Britta
    Wuest, Monika
    Orjeda, Christian
    Harel, Dipak
    Varghese, Shaji
    Gore, Vikas
    Patil, Meenal
    Gayke, Deepak
    Herdemann, Matthias
    Heit, Isabelle
    Zaliani, Andrea
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (12) : 4547 - 4559
  • [30] Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma
    Mamand, Sarni
    Allchin, Rebecca L.
    Ahearne, Matthew J.
    Wagner, Simon D.
    SCIENTIFIC REPORTS, 2018, 8